InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (33 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
33
T+90 hit rate
0%
T+90 mean return
-4.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Cheng Andrew, Chief Executive Officer. Officer active across 2 companies, notably Akero Therapeutics, Inc.. Cumulatively, 77 disclosures have been published. Breakdown: 0 buy · 33 sells. Total volume traded: €15.3m. Activity tracked since 2 July 2021. The latest transaction was filed on 10 October 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations77 total
277,075 sharesCommon StockSEC:0001193125-25-312131
277,075 sharesCommon StockSEC:0001193125-25-312131:0
159,762 sharesCommon StockSEC:0001193125-25-312131:1
30,000 shares@ US$19.872.5% of flowCommon StockSEC:0001193125-25-239343:0
30,000 shares@ US$53.9786.7% of flowCommon StockSEC:0001193125-25-239343:1
7,200 shares@ US$41.001.3% of flowCommon StockSEC:0000950170-25-070811:0
22,800 shares@ US$41.6344.1% of flowCommon StockSEC:0000950170-25-070811:1
30,000 shares@ US$35.2264.5% of flowCommon StockSEC:0000950170-25-053391:0
1,738 shares@ US$44.880.3% of flowCommon StockSEC:0000950170-25-039765:0
28,784 shares@ US$41.7465.3% of flowCommon StockSEC:0000950170-25-038177:0
6,439 shares@ US$52.9081.6% of flowCommon StockSEC:0000950170-25-018311:1
749 shares@ US$54.5460.2% of flowCommon StockSEC:0000950170-25-018311:3
12,640 shares@ US$51.7523.1% of flowCommon StockSEC:0000950170-25-018311:0
9,972 shares@ US$53.6662.5% of flowCommon StockSEC:0000950170-25-018311:2
200 shares@ US$55.810.1% of flowCommon StockSEC:0000950170-25-018311:4
24,242 shares@ US$54.566.1% of flowCommon StockSEC:0000950170-25-010705:0
50,000 shares@ US$0.6150.1% of flowCommon StockSEC:0000950170-25-009324:0
98,500 shares0Common StockSEC:0000950170-24-138132:0
7,855 shares@ US$30.791.1% of flowCommon StockSEC:0000950170-24-136017:0
25,000 shares@ US$21.102.4% of flowCommon StockSEC:0000950170-24-133435:0
81,280 shares@ US$21.107.6% of flowCommon StockSEC:0000950170-24-121100:0
81,280 shares@ US$31.47211.3% of flowCommon StockSEC:0000950170-24-121100:1
27,086 shares@ US$21.102.5% of flowCommon StockSEC:0000950170-24-121100:2
27,086 shares@ US$32.4993.9% of flowCommon StockSEC:0000950170-24-121100:3
24,992 shares@ US$21.102.3% of flowCommon StockSEC:0000950170-24-115731:0
25 of 77 declarations
About Cheng Andrew
Cheng Andrew is the Chief Executive Officer of Akero Therapeutics, Inc. He oversees the company's operations and strategy.
